Nuevas formas de vehiculización de agentes hipotensores para el tratamiento del glaucoma

  1. Andres Guerrero, Vanessa
Dirigée par:
  1. María del Rocío Herrero Vanrell Directrice
  2. Irene Teresa Molina Martínez Directrice

Université de défendre: Universidad Complutense de Madrid

Fecha de defensa: 29 juin 2011

Jury:
  1. Julián García Feijoo President
  2. Beatriz de las Heras Polo Secrétaire
  3. Virginia Merino Sanjuán Rapporteur
  4. Nicolas Tsapis Rapporteur
  5. Carmen Álvarez Lorenzo Rapporteur
Département:
  1. Farmacia Galénica y Tecnología Alimentaria

Type: Thèses

Teseo: 113230 DIALNET

Résumé

Glaucoma is the second leading cause of blin dness in the world. It is a chronic optic neuropathy which can lead to complete loss of vision if an adequate treatment is not used in time. At the moment there is no cure for glaucoma and the available treatments are chronic and only manage to contr ol or decrease the evolution of the pathology. These types of treatments, consisting of the instillation of eye drops once or twice per day, are usually associated to short- and long-term adverse effects that compromise the patient compliance...